| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | WxxW_domain | 9.24e-05 | 6 | 47 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 9.24e-05 | 6 | 47 | 2 | PF13330 | |
| Domain | Unchr_dom_Cys-rich | 4.75e-04 | 13 | 47 | 2 | IPR014853 | |
| Domain | C8 | 4.75e-04 | 13 | 47 | 2 | SM00832 | |
| Domain | TIL_dom | 5.53e-04 | 14 | 47 | 2 | IPR002919 | |
| Domain | BBOX | 6.97e-04 | 69 | 47 | 3 | SM00336 | |
| Domain | VWD | 7.27e-04 | 16 | 47 | 2 | SM00216 | |
| Domain | VWF_type-D | 7.27e-04 | 16 | 47 | 2 | IPR001846 | |
| Domain | VWFD | 7.27e-04 | 16 | 47 | 2 | PS51233 | |
| Domain | VWD | 7.27e-04 | 16 | 47 | 2 | PF00094 | |
| Domain | - | 7.57e-04 | 71 | 47 | 3 | 4.10.45.10 | |
| Domain | zf-B_box | 7.89e-04 | 72 | 47 | 3 | PF00643 | |
| Domain | CarboxyPept-like_regulatory | 8.23e-04 | 17 | 47 | 2 | IPR008969 | |
| Domain | CTCK_1 | 9.24e-04 | 18 | 47 | 2 | PS01185 | |
| Domain | VWC_out | 1.03e-03 | 19 | 47 | 2 | SM00215 | |
| Domain | 2OG-FeII_Oxy | 1.03e-03 | 19 | 47 | 2 | PF03171 | |
| Domain | ZF_BBOX | 1.07e-03 | 80 | 47 | 3 | PS50119 | |
| Domain | Znf_B-box | 1.11e-03 | 81 | 47 | 3 | IPR000315 | |
| Domain | CT | 1.39e-03 | 22 | 47 | 2 | SM00041 | |
| Domain | Oxoglu/Fe-dep_dioxygenase | 1.52e-03 | 23 | 47 | 2 | IPR005123 | |
| Domain | Cys_knot_C | 1.79e-03 | 25 | 47 | 2 | IPR006207 | |
| Domain | CTCK_2 | 1.79e-03 | 25 | 47 | 2 | PS01225 | |
| Domain | zf-C3HC4 | 2.36e-03 | 223 | 47 | 4 | PF00097 | |
| Domain | EGF_CA | 3.58e-03 | 122 | 47 | 3 | SM00179 | |
| Domain | VWFC_1 | 3.70e-03 | 36 | 47 | 2 | PS01208 | |
| Domain | EGF-like_Ca-bd_dom | 3.74e-03 | 124 | 47 | 3 | IPR001881 | |
| Domain | VWC | 4.11e-03 | 38 | 47 | 2 | SM00214 | |
| Domain | VWFC_2 | 4.11e-03 | 38 | 47 | 2 | PS50184 | |
| Domain | VWF_dom | 5.01e-03 | 42 | 47 | 2 | IPR001007 | |
| Domain | ZF_RING_1 | 6.08e-03 | 291 | 47 | 4 | PS00518 | |
| Domain | ZF_RING_2 | 6.61e-03 | 298 | 47 | 4 | PS50089 | |
| Domain | RING | 7.16e-03 | 305 | 47 | 4 | SM00184 | |
| Domain | LRRNT | 7.87e-03 | 53 | 47 | 2 | PF01462 | |
| Domain | Znf_RING_CS | 7.99e-03 | 163 | 47 | 3 | IPR017907 | |
| Domain | Znf_RING | 9.01e-03 | 326 | 47 | 4 | IPR001841 | |
| Domain | Znf_C3HC4_RING-type | 9.25e-03 | 172 | 47 | 3 | IPR018957 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 1.80e-06 | 146 | 48 | 5 | 20686565 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 7705663 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 8668193 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27012201 | ||
| Pubmed | The Wnt signaling pathway has tumor suppressor properties in retinoblastoma. | 1.87e-06 | 2 | 48 | 2 | 16930536 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 12374798 | ||
| Pubmed | 1.98e-06 | 18 | 48 | 3 | 18187417 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 29706651 | ||
| Pubmed | Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells. | 5.59e-06 | 3 | 48 | 2 | 30454706 | |
| Pubmed | Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice. | 5.59e-06 | 3 | 48 | 2 | 20829439 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21691831 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 36548516 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 15824740 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.09e-05 | 211 | 48 | 5 | 24097068 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 12459555 | ||
| Pubmed | KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. | 1.12e-05 | 4 | 48 | 2 | 17056014 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 18987386 | ||
| Pubmed | Newly identified loci that influence lipid concentrations and risk of coronary artery disease. | 1.57e-05 | 35 | 48 | 3 | 18193043 | |
| Pubmed | MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. | 1.86e-05 | 5 | 48 | 2 | 16107876 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 21940674 | ||
| Pubmed | TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancer. | 1.86e-05 | 5 | 48 | 2 | 36882525 | |
| Pubmed | DNA-binding regulates site-specific ubiquitination of IRF-1. | 2.79e-05 | 6 | 48 | 2 | 23134341 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 12915301 | ||
| Pubmed | Genetic variants influencing circulating lipid levels and risk of coronary artery disease. | 4.35e-05 | 49 | 48 | 3 | 20864672 | |
| Pubmed | Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. | 5.19e-05 | 8 | 48 | 2 | 14605369 | |
| Pubmed | RUSC2 and WDR47 oppositely regulate kinesin-1-dependent distribution of ATG9A to the cell periphery. | 5.19e-05 | 8 | 48 | 2 | 34432492 | |
| Pubmed | Common variants at 30 loci contribute to polygenic dyslipidemia. | 5.82e-05 | 54 | 48 | 3 | 19060906 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 19487539 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 22542455 | ||
| Pubmed | The isthmic neuroepithelium is essential for cerebellar midline fusion. | 8.33e-05 | 10 | 48 | 2 | 14507778 | |
| Pubmed | Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2. | 1.02e-04 | 11 | 48 | 2 | 37379210 | |
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 20570916 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 28276606 | ||
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 1377062 | ||
| Pubmed | Innate neural stem cell heterogeneity determines the patterning of glioma formation in children. | 1.22e-04 | 12 | 48 | 2 | 22789544 | |
| Pubmed | Mapping of the mouse Rar loci encoding retinoic acid receptors RAR alpha, RAR beta and RAR gamma. | 1.22e-04 | 12 | 48 | 2 | 8251184 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 27249653 | ||
| Pubmed | Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways. | 1.44e-04 | 13 | 48 | 2 | 20858735 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 1.55e-04 | 75 | 48 | 3 | 15372022 | |
| Pubmed | A simple method for 3D analysis of immunolabeled axonal tracts in a transparent nervous system. | 1.94e-04 | 15 | 48 | 2 | 25456121 | |
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 20160193 | ||
| Pubmed | DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis. | 2.21e-04 | 16 | 48 | 2 | 28123024 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 24793032 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 32994318 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 20301471 | ||
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 19656773 | ||
| Pubmed | TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins. | 4.23e-04 | 22 | 48 | 2 | 17803295 | |
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 35792897 | ||
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 31197172 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 5.45e-04 | 486 | 48 | 5 | 30940648 | |
| Pubmed | Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. | 5.48e-04 | 25 | 48 | 2 | 34391772 | |
| Pubmed | 5.48e-04 | 25 | 48 | 2 | 32737294 | ||
| Pubmed | 5.48e-04 | 25 | 48 | 2 | 15809042 | ||
| Pubmed | 6.89e-04 | 28 | 48 | 2 | 34163012 | ||
| Pubmed | 7.39e-04 | 29 | 48 | 2 | 20972250 | ||
| Pubmed | A three-stage genome-wide association study of general cognitive ability: hunting the small effects. | 7.39e-04 | 29 | 48 | 2 | 20306291 | |
| Pubmed | 7.92e-04 | 30 | 48 | 2 | 21880902 | ||
| Pubmed | Nkx6-1 controls the identity and fate of red nucleus and oculomotor neurons in the mouse midbrain. | 8.45e-04 | 31 | 48 | 2 | 19592574 | |
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 9169087 | ||
| Pubmed | MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. | 9.01e-04 | 32 | 48 | 2 | 20864041 | |
| Pubmed | Distinct roles and regulations for HoxD genes in metanephric kidney development. | 9.58e-04 | 33 | 48 | 2 | 18159948 | |
| Pubmed | 9.58e-04 | 33 | 48 | 2 | 18193044 | ||
| Pubmed | 1.02e-03 | 34 | 48 | 2 | 26411367 | ||
| Pubmed | 1.14e-03 | 36 | 48 | 2 | 32703236 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 1.19e-03 | 336 | 48 | 4 | 31253590 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.23e-03 | 583 | 48 | 5 | 29844126 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.19e-04 | 95 | 28 | 3 | 59 | |
| GeneFamily | Ring finger proteins | 8.04e-04 | 275 | 28 | 4 | 58 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-07 | 162 | 47 | 5 | 4b9f80f701dcbb2508f497095cb8a7a2ca51cb5e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Cplx3-Hs6st2_(Entorhinal_cortex)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.10e-07 | 68 | 47 | 4 | 01ba0ccc5732189a5c0c32cb7819289102711b93 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Cplx3-Hs6st2_(Entorhinal_cortex)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.10e-07 | 68 | 47 | 4 | 75e81b353ef313d5e98d5c98d584335f1d1fa658 | |
| ToppCell | Healthy_donor-CD8+_Tem|Healthy_donor / disease group, cell group and cell class (v2) | 1.87e-06 | 194 | 47 | 5 | bf2e889de60b2b452a41f4d59a0f2a1865f07184 | |
| ToppCell | Healthy/Control-CD8+_Tem|Healthy/Control / Disease group and Cell class | 1.92e-06 | 195 | 47 | 5 | f4955c176c4918052dc151c5e5249223ec428272 | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 1.97e-06 | 196 | 47 | 5 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 138 | 47 | 4 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 138 | 47 | 4 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 147 | 47 | 4 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 148 | 47 | 4 | 1186ee0d15244fee74c1d09df3967c1b69f8ddce | |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 2.44e-05 | 160 | 47 | 4 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.50e-05 | 161 | 47 | 4 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-05 | 162 | 47 | 4 | 3b89c3758835b7b9f9d4fb0bc8ed06da382fe48b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-05 | 167 | 47 | 4 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 169 | 47 | 4 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 169 | 47 | 4 | 89b5452e0d8d058648a1d2659f1611fd6aebc6b6 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.09e-05 | 170 | 47 | 4 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 174 | 47 | 4 | 6b362b8a934a4fe6a1dd867b7c448cb3fb3ffd6a | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-05 | 178 | 47 | 4 | a96941fef62c2f4533c557ef825ae3265f8f52db | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.86e-05 | 180 | 47 | 4 | 557453b74d4a9cc95ed1c7b9a9a58e45eb02ed6a | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TEM|Control / Disease, Lineage and Cell Type | 4.48e-05 | 187 | 47 | 4 | 7fdff970a9397305d0b8194c00a043cc69dcca12 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 4.67e-05 | 189 | 47 | 4 | f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 4.77e-05 | 190 | 47 | 4 | e1f474dc36bf9eaf457b14a8761d287904754cdc | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 190 | 47 | 4 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 4.97e-05 | 192 | 47 | 4 | f53426b9b1a63529307751c490a5a6214e499317 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-pDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.07e-05 | 193 | 47 | 4 | 2a48e72f3df2ad64e1680fca759be8fd2190771e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.17e-05 | 194 | 47 | 4 | ac03be73fdc32dacd4a450c0fb28617e043b8444 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.17e-05 | 194 | 47 | 4 | 7ab4418a8a12c488d74af3676bdac672628da80c | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.17e-05 | 194 | 47 | 4 | 13c3674d601c8a7355ce869de1af6401938c0037 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.17e-05 | 194 | 47 | 4 | 760761ce7d22edf9a8cec71e8ab0caa273fce3f7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.17e-05 | 194 | 47 | 4 | e72be6dc2711c1d4f16943c8615cf9dc2e961ff3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.27e-05 | 195 | 47 | 4 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.27e-05 | 195 | 47 | 4 | 14a6466524c22920daa622fbc710daf1defb46c3 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.27e-05 | 195 | 47 | 4 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.38e-05 | 196 | 47 | 4 | a8217c8e27027c0444ce072fe194404345c34022 | |
| ToppCell | Healthy_donor-CD8+_Tem|World / disease group, cell group and cell class (v2) | 5.38e-05 | 196 | 47 | 4 | b04684d319d0c462862677d0f956a389bffef535 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 5.38e-05 | 196 | 47 | 4 | f23c33ad10f933250be98e8389a9aa278e876f96 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 5.38e-05 | 196 | 47 | 4 | 2bf0f36af1d0934c03999dbbff3c51ae9432386d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-05 | 196 | 47 | 4 | a2db88fad9bbc55685f8e681d120ef38715ca3c4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-05 | 196 | 47 | 4 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.38e-05 | 196 | 47 | 4 | d83acd9abd7b296989b8ae09da63799e6877a149 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.49e-05 | 197 | 47 | 4 | 836fcb20d3a1f9cf14f6fd505fbb6bad4650fd28 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.49e-05 | 197 | 47 | 4 | 902e2ce011a938c1de39ff53ebbb2ec5557e48bc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-05 | 197 | 47 | 4 | 0e93800d5df652a9c691c66a3f75a2e8979aed8e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.49e-05 | 197 | 47 | 4 | 3b08b190b7d4ddd4c66a5b6015df777fc2f6f9e3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.49e-05 | 197 | 47 | 4 | 8e41e6cda38eace961cb1a56f4df24468c66b956 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.49e-05 | 197 | 47 | 4 | adb8c21351ae1cf3d834b3dc8a8da512cb0ea68b | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.49e-05 | 197 | 47 | 4 | e2e7bc8e6c45c987d91cc3ee504fc5af130a69fe | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD3|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.49e-05 | 197 | 47 | 4 | 46f82cce0f3c3ddb087953949e76aae19dc8bbf3 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 5.49e-05 | 197 | 47 | 4 | 13e6611cde9364f0c1bf681b0b26c4d2725e5f4a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.49e-05 | 197 | 47 | 4 | 35004d4728d33f15cc3be99a073b1ea965365c32 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.49e-05 | 197 | 47 | 4 | 99f29fa06c96c399a48ea1fc82fbedd4f4256a99 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tem/emra_CD8|Liver / Manually curated celltypes from each tissue | 5.60e-05 | 198 | 47 | 4 | 2fc2a4638c458ae793ac090a29d27b75fc9e6af6 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-05 | 198 | 47 | 4 | 3c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-05 | 198 | 47 | 4 | 9ce9b3721fb8a154667211c29e60133412134c76 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_Tem|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.60e-05 | 198 | 47 | 4 | a7519bbbb67d319635ddbe05a2a154c46b77ce87 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 7642a6bc957ecb5953e966ba296b9f4deb368364 | |
| ToppCell | (1)_T_cell-(10)_CD8_T|(1)_T_cell / shred on Cell_type and subtype | 5.71e-05 | 199 | 47 | 4 | d04896156e9ef6dda5f4f69fefdc7038c617d969 | |
| ToppCell | cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.71e-05 | 199 | 47 | 4 | f96a6b95329ec6642b3a528c9e346ab3e1733c25 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-gd_T|Influenza_Severe / Disease, condition lineage and cell class | 5.71e-05 | 199 | 47 | 4 | b1ecc8aa5a98fe42d678ab07b310d62ebaacdecf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Mild / Disease, condition lineage and cell class | 5.82e-05 | 200 | 47 | 4 | 7ea4f439f03099da474ac8c04a07bbbde77dafc6 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | b76f000582b38f4c61b44081eba9ae213382cb6f | |
| ToppCell | mild-CD8+_Tem|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.82e-05 | 200 | 47 | 4 | a7870c5728b2c17d1d0e4fe728599f186966861b | |
| ToppCell | Sigmoid-(1)_T_cell-(10)_CD8_T|Sigmoid / shred on region, Cell_type, and subtype | 5.82e-05 | 200 | 47 | 4 | 0ab99bab8837cccadaede807db60d1a5349633af | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 200 | 47 | 4 | 69295705fc614c2687f2b6c8e6aa0c6717841008 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-05 | 200 | 47 | 4 | dc719c7f0ffee0db4f56f1991e47974dc7bef11b | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Sigmoid-T_cell-CD8_T|Sigmoid / Region, Cell class and subclass | 5.82e-05 | 200 | 47 | 4 | f389f382480149be61026f34bf04fd92f5c5a351 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 107 | 47 | 3 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 107 | 47 | 3 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.24e-04 | 139 | 47 | 3 | a542ef99ba57f364ea9707b3119e11f5a240034c | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.60e-04 | 143 | 47 | 3 | d877d914e4e74db2053baa310d318d6440e672bc | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 5.09e-04 | 148 | 47 | 3 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | VE-CD8-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 5.09e-04 | 148 | 47 | 3 | f49f579650b57cc4c6c7a7fa726447740d3dc695 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.39e-04 | 151 | 47 | 3 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.39e-04 | 151 | 47 | 3 | 512f7f37ddc8dfa1906f7fff92b571929236c9ea | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.60e-04 | 153 | 47 | 3 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-04 | 153 | 47 | 3 | 0a4fbe46125b05ee235deb528855808c2bf33cba | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-04 | 154 | 47 | 3 | 3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-04 | 154 | 47 | 3 | ee03b386d28a524084eaf1c0091f7389daa34250 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-04 | 155 | 47 | 3 | 583cfaa41c755c63aee312eb442e9d97f645d5f7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1-Excitatory_Neuron.Slc17a7.Parm1.Cadm2_(Deep_layer_pyramidal_cells--layer_5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.87e-04 | 34 | 47 | 2 | c217c09c1d7e84f14b9e0d1e7c6e8e916b3c7d10 | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.04e-04 | 157 | 47 | 3 | e9eb56a1dd96bd2e9725a20f2cf70ddeab811bd6 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.04e-04 | 157 | 47 | 3 | f2bc60ec0305b056d79f1b7fd6b5e3730d606916 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 157 | 47 | 3 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 157 | 47 | 3 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.04e-04 | 157 | 47 | 3 | 5fb41af247465aa29aa7b8edd26e3d3794766f80 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 157 | 47 | 3 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.04e-04 | 157 | 47 | 3 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 157 | 47 | 3 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.15e-04 | 158 | 47 | 3 | 390b9c455ed15a6804613eecfd2776949dfba146 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.15e-04 | 158 | 47 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-04 | 159 | 47 | 3 | 2fb1d2ff52920aeb48d048cf29f0cd45f944a73d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.38e-04 | 160 | 47 | 3 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-04 | 160 | 47 | 3 | 1a9329d8183296f36928bd9e96f10db9f04ce326 | |
| ToppCell | 367C-Lymphocytic-ILC|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-04 | 160 | 47 | 3 | f70ec054b6d51c1565e4a257cbe3c9537c0eb09f | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|metastatic_Brain / Location, Cell class and cell subclass | 6.38e-04 | 160 | 47 | 3 | bc86c6ba1b7815ab944e1ec9da703f469373b8b1 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-gdT|ICU-NoSEP / Disease, Lineage and Cell Type | 6.38e-04 | 160 | 47 | 3 | 2798c5bd971407f27dd4d3a4831d63d9c88003c3 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 6.50e-04 | 161 | 47 | 3 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 161 | 47 | 3 | 54eda81a570e422b35fcea799e640c7654122969 | |
| Disease | thrombospondin type-1 domain-containing protein 1 measurement | 2.27e-05 | 5 | 45 | 2 | EFO_0802131 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 3.19e-05 | 118 | 45 | 4 | EFO_0010119 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 5.81e-05 | 49 | 45 | 3 | EFO_0021897 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 8.23e-05 | 55 | 45 | 3 | EFO_0022288 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 8.78e-05 | 153 | 45 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.98e-04 | 189 | 45 | 4 | EFO_0009932 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 3.05e-04 | 17 | 45 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | ischemia (biomarker_via_orthology) | 3.43e-04 | 18 | 45 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | apolipoprotein B measurement | 4.86e-04 | 663 | 45 | 6 | EFO_0004615 | |
| Disease | docosahexaenoic acid measurement | 9.68e-04 | 127 | 45 | 3 | EFO_0007761 | |
| Disease | RS-warfarin measurement | 9.90e-04 | 128 | 45 | 3 | EFO_0803325 | |
| Disease | esterified cholesterol measurement | 9.90e-04 | 128 | 45 | 3 | EFO_0008589 | |
| Disease | total lipids in small HDL measurement | 1.31e-03 | 35 | 45 | 2 | EFO_0022311 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 1.31e-03 | 35 | 45 | 2 | EFO_0004458, EFO_0004611 | |
| Disease | free cholesterol in small HDL measurement | 1.31e-03 | 35 | 45 | 2 | EFO_0022270 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.34e-03 | 315 | 45 | 4 | EFO_0004612, EFO_0008591 | |
| Disease | Nephroblastoma | 1.39e-03 | 36 | 45 | 2 | C0027708 | |
| Disease | Adenoma, Microcystic | 1.39e-03 | 36 | 45 | 2 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.39e-03 | 36 | 45 | 2 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.39e-03 | 36 | 45 | 2 | C0205646 | |
| Disease | Follicular adenoma | 1.39e-03 | 36 | 45 | 2 | C0205647 | |
| Disease | Papillary adenoma | 1.39e-03 | 36 | 45 | 2 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.39e-03 | 36 | 45 | 2 | C0205651 | |
| Disease | Adenoma | 1.39e-03 | 36 | 45 | 2 | C0001430 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.44e-03 | 321 | 45 | 4 | EFO_0004612, EFO_0004639 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.46e-03 | 37 | 45 | 2 | EFO_0022281 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IHRRHIEARRVCVTF | 256 | Q9NXW9 | |
| VVEALCTLRGRRCHC | 136 | Q8N9P6 | |
| CLCRVAVRRALGKHR | 301 | Q9Y576 | |
| RAVECCVRLLHVRNG | 161 | Q92624 | |
| DTPLICACRRGHVRI | 41 | Q5VYY1 | |
| CACRRGHVRIVSFLL | 46 | Q5VYY1 | |
| RCRHAGCGQVLLRRD | 111 | Q9UPQ7 | |
| LCEVVEHACRSDGRR | 136 | P30203 | |
| HRRCRQRACGLLTAE | 116 | O15528 | |
| NAIERFCGEVRRLCH | 131 | Q7L576 | |
| FCGEVRRLCHAERRK | 136 | Q7L576 | |
| EDGVCIRRCTVLRDA | 281 | Q9Y5P6 | |
| DAIRPRCVELRHLCD | 396 | Q86YR7 | |
| LSRCGRRRVDHFLCE | 166 | A6NFC9 | |
| RVLVCGVLDERSRCA | 496 | Q8WWZ8 | |
| VCRDGRLHCRQIRLI | 741 | Q02817 | |
| EVRVCACPGRDRRTE | 271 | P04637 | |
| RLREIRTRCARHCAA | 76 | Q8IVL5 | |
| REELCRRRAECSIHL | 91 | Q9Y5H7 | |
| VGGRRCCVIRDHLLA | 66 | P60673 | |
| DLCLRLLRHCGSRIS | 1461 | Q96HP0 | |
| SLGVAIHLCCRRRRA | 186 | P10966 | |
| VVDLRIRAARGSCVC | 601 | Q8IZJ3 | |
| RDLRHALLRLVCCGR | 311 | Q9H228 | |
| CCRRRKRSDDHLIPI | 551 | Q8IZK6 | |
| ALHFCRAVCRRAERR | 181 | Q96EY8 | |
| RARLERCHGVSVALR | 751 | Q53GL7 | |
| ERGCSVRCDRAGLLR | 41 | Q9GZU5 | |
| RSRFHKARCGCRREE | 511 | Q14D33 | |
| AREAIRRLRATCHVV | 781 | Q15345 | |
| RICRCLEGHIQCRQR | 276 | Q6ZWJ8 | |
| RCRRCVVVGNGHRLR | 116 | Q11206 | |
| RRHRSLTRGRCGKEC | 6 | Q9NT68 | |
| LRGCCTVALHSIRRI | 461 | O15079 | |
| RCCSVRRLERREIHC | 436 | Q8IUL8 | |
| AVRACILCVHPRTRV | 326 | Q14690 | |
| RAICVVCDRAREHRE | 146 | Q9C029 | |
| TVRIREASLRAHRCV | 36 | Q96K62 | |
| SRALCIHTGRELRCK | 106 | Q96RU8 | |
| VTRARRHVAVICDSR | 601 | P38935 | |
| RCVHCRALFRRRADG | 296 | Q2MJR0 | |
| CGDGVRERRRVCLTS | 356 | Q9NS62 | |
| RTDRLLKHRRTCGEV | 356 | Q9Y2X9 | |
| SCDREISCRGERIRD | 1446 | O94813 | |
| GRIRLRRIDAFCTCL | 316 | Q5SNT2 | |
| CAAVEACVLHGLRRR | 46 | Q2NKQ1 | |
| GIELHCIRRCDRVTR | 266 | O15213 | |
| ELLCCGRGHRTRTQR | 326 | P04628 | |
| VCTVRECRLHERALL | 116 | Q6PJ69 | |
| LLEHCGVCRERLRPE | 61 | Q13263 |